Preliminary Study Shows Safety of Bone Marrow-Derived Stem Cell Transplantation after Traumatic Brain Injury
[Source: Newswise]
For children with severe traumatic brain injury (TBI), transplantation of stem cells derived from the patients’ own bone marrow is a “logistically feasible and safe” treatment procedure, reports the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
The study paves the way for further research to evaluate whether treatment with autologous bone marrow-derived mononuclear cells (BMMNCs) can enhance brain recovery after TBI in children. The lead author was Dr. Charles S. Cox, Jr., professor of pediatric neurosurgery at The University of Texas Health Science Center at Houston (UT Health) Medical School.
Read the Rest of this Article/Press Release on Newswise.com